We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 09 OCTOBER 2017
The Latest: Integra Forced To Divest Neurosurgical Tools To Gain FTC Clearance
McDermott Will & Emery
On February 14, 2017, Integra agreed to purchase Johnson & Johnson's Codman neurosurgery business (excluding Codman's neurovascular and drug deliver businesses) for $1.045 billion.
United StatesAntitrust/Competition Law










